Skip to main content

Pharmacotherapy for Contraception and Menstruation Control

An overview of pharmacologic options for contraception and menstruation control, including combined oral contraceptives (COCs) and progestin-only contraceptives. Discusses mechanisms of action, progestin generations, dosing regimens, missed dose protocols, clinical considerations, contraindications, and drug interactio

Save this reading to your study set

Sign up free

Contraception is a cornerstone of reproductive healthcare, offering patients various methods to manage pregnancy prevention and menstrual cycles. Pharmacologic options range from daily oral pills to long-acting hormonal implants and intrauterine devices (IUDs). Understanding the nuances of these medications—specifically how they interact with the body's endocrine system and how they respond to other drugs—is essential for clinical practice and patient safety.

Combined Oral Contraceptives (COCs)

Combined Oral Contraceptives (COCs) are among the most common methods of birth control. As the name suggests, they contain two primary hormones: estrogen (typically ethinyl estradiol) and progestin.

Mechanism of Action

The efficacy of COCs relies on a dual-action approach to prevent pregnancy:

  • Estrogen: This component suppresses the release of Follicle-Stimulating Hormone (FSH) from the pituitary gland, which inhibits the maturation of ovarian follicles.
  • Progestin: This component acts on the hypothalamus and pituitary to suppress the midcycle Luteinizing Hormone (LH) surge, thereby preventing ovulation. Additionally, progestin thickens the cervical mucus, creating a physical barrier that makes it difficult for sperm to penetrate the uterus.
This illustration displays various methods of contraception, including pills, IUDs, injections, implants, patches, vaginal rings, and barrier methods.
This illustration displays various methods of contraception, including pills, IUDs, injections, implants, patches, vaginal rings, and barrier methods.

Progestin Generations and Side Effects

Not all COCs are created equal. The specific type of progestin used can significantly influence a patient's side effect profile, particularly regarding androgenic (male-pattern hormone) effects and the risk of blood clots.

GenerationExampleAndrogenic EffectsThrombosis Risk
1st1^{\text{st}} GenNorethindroneMild (may cause acne/hirsutism)Lower
2nd2^{\text{nd}} GenLevonorgestrelHigherHigher
3rd3^{\text{rd}} GenDesogestrelLowerHigher
4th4^{\text{th}} GenDrospirenoneLowestHighest

Clinical Note: While 4th4^{\text{th}} generation progestins like drospirenone are excellent for managing acne due to their low androgenic activity, they carry the highest risk of thrombosis and can also lead to hyperkalemia.

Keep reading for free.

Create an account to finish this reading and make it part of your study routine.

Continue reading free

Already have an account? Log in

Updated

Study it your way.

Import this reading into your study set to get started with another study mode.

Make it your own.

Keep this reading in a new study set, or add it to one you already use.